RIVAROXABAN Mepha cpr pell 15 mg bte 100 pce

7680684390128 CH-68439 B01AF01 06.03.0.

Reimbursement limitations:

XARELTO15,20

Une prise en charge des indications autorisées par Swissmedic intervient uniquement chez les adultes adultes.

RIVAROXABAN Mepha cpr pell 15 mg bte 100 pce
RIVAROXABAN Mepha cpr pell 15 mg bte 100 pce
RIVAROXABAN Mepha cpr pell 15 mg bte 100 pce
1 / 3
google

Details

Product number
6843902
CPT
-
Packaging group
100
Unit
Tablette(n)
Composition
rivaroxabanum 15 mg, natrii laurilsulfas, lactosum monohydricum 125.4 mg, hypromellosum, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (flavum), E 172 (rubrum), pro compresso obducto corresp. natrium max. 0.89 mg.

Articles (1)

Rivaroxaban-Mepha 15 mg, Filmtabletten
Filmtabletten
100
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
18/09/2024
Patient information leaflet
Français
18/09/2024
Patient information leaflet
Italien
18/09/2024
Professional SmPC
Allemand
18/09/2024
Professional SmPC
Français
18/09/2024
Professional SmPC
Italien
18/09/2024

Detailed composition

Substance Quantity Type Category
(N/A)
15.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
125.4 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HBESI

Reimbursement information

Public price
CHF 74.75
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/08/2024

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
68439
Drug name
Rivaroxaban-Mepha, Filmtabletten
Galenic form
FILM
ATC Code
B01AF01
Authorization status
Z
Dispensation category
B
First authorization
15/03/2022
Authorization expiration date
14/03/2027
IT number
06.03.0.
Domain
Human medicine
Field of application
Thromboseprophylaxe und Behandlung, Schlaganfall- und Embolieprophylaxe, Behandlung von Lungenembolien (LE)

Packaging details

Description (FR)
RIVAROXABAN Mepha cpr pell 15 mg bte 100 pce
Description (DE)
RIVAROXABAN Mepha Filmtabl 15 mg Ds 100 Stk
Market launch
15/03/2022
Narcotic (BTM)
No

Original drug

Xarelto, Filmtabletten
GTIN: 7680587280014
CHF 17.25
View original

Other packaging sizes

RIVAROXABAN Mepha cpr pell 10 mg 14 pce
14 TABL
GTIN: 7680684390012
View
RIVAROXABAN Mepha cpr pell 10 mg 28 pce
28 TABL
GTIN: 7680684390029
View
RIVAROXABAN Mepha cpr pell 10 mg 98 pce
98 TABL
GTIN: 7680684390036
View
RIVAROXABAN Mepha cpr pell 10 mg bte 100 pce
100 TABL
GTIN: 7680684390043
View
RIVAROXABAN Mepha cpr pell 15 mg 14 pce
14 TABL
GTIN: 7680684390050
View
RIVAROXABAN Mepha cpr pell 15 mg 28 pce
28 TABL
GTIN: 7680684390067
View
RIVAROXABAN Mepha cpr pell 15 mg 98 pce
98 TABL
GTIN: 7680684390074
View
RIVAROXABAN Mepha cpr pell 20 mg 14 pce
14 TABL
GTIN: 7680684390081
View
RIVAROXABAN Mepha cpr pell 20 mg 28 pce
28 TABL
GTIN: 7680684390098
View
RIVAROXABAN Mepha cpr pell 20 mg 98 pce
98 TABL
GTIN: 7680684390104
View